Tetraphase lines up a new FDA pitch for antibiotic after it comes through in latest PhIII
A little more than a year after the FDA sent Tetraphase back to the Phase III drawing board after dissing their application for the antibiotic …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
